Paper24674015
Local failure patterns for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy.
Li JX and 7 others. Radiat Oncol, 2014. Cited by 57 papers, by iCite.
Cite this record
ConductScience Library. Local failure patterns for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy. Papers, record 24674015. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24674015
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Local failure patterns for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nasopharyngeal Neoplasms | Major topic |
| Neoplasm Recurrence, Local | Major topic |
| Radiotherapy, Intensity-Modulated | Major topic |
| Adult | |
| Aged | |
| Carcinoma | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Magnetic Resonance Spectroscopy | |
| Male | |
| Middle Aged | |
| Nasopharyngeal Carcinoma | |
| Neoplasm Invasiveness | |
| Radiotherapy Dosage | |
| Treatment Failure | |
| Tumor Burden | |
| Young Adult |
Source PubMed
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19564532 | Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. | J Clin Oncol | 2009 | https://conductscience.org/library/papers/19564532 | PubMed |
| 2 | 9510041 | A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. | Radiother Oncol | 1998 | https://conductscience.org/library/papers/9510041 | PubMed |
| 3 | 16626829 | Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG). | Radiother Oncol | 2006 | https://conductscience.org/library/papers/16626829 | PubMed |
| 4 | 17869020 | Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study. | Int J Radiat Oncol Biol Phys | 2008 | https://conductscience.org/library/papers/17869020 | PubMed |
| 5 | 15752890 | Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. | Int J Radiat Oncol Biol Phys | 2005 | https://conductscience.org/library/papers/15752890 | PubMed |
| 6 | 17869667 | Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer. | Int J Radiat Oncol Biol Phys | 2007 | https://conductscience.org/library/papers/17869667 | PubMed |
| 7 | 7620219 | Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors. | Oncol Res | 1994 | https://conductscience.org/library/papers/7620219 | PubMed |
| 8 | 12527043 | Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. | Int J Radiat Oncol Biol Phys | 2003 | https://conductscience.org/library/papers/12527043 | PubMed |
| 9 | 19386431 | Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre singapore experience. | Int J Radiat Oncol Biol Phys | 2009 | https://conductscience.org/library/papers/19386431 | PubMed |
| 10 | 12007936 | Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. | Int J Radiat Oncol Biol Phys | 2002 | https://conductscience.org/library/papers/12007936 | PubMed |
| 11 | 22178121 | Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial. | Lancet Oncol | 2012 | https://conductscience.org/library/papers/22178121 | PubMed |
| 12 | 2293704 | Functional endoscopic sinus surgery: evaluation, surgery, and follow-up of 250 patients. | Laryngoscope | 1990 | https://conductscience.org/library/papers/2293704 | PubMed |
| 13 | 19362784 | Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series. | Int J Radiat Oncol Biol Phys | 2009 | https://conductscience.org/library/papers/19362784 | PubMed |
| 14 | 889677 | Influence of tumour size on hypoxic fraction and therapeutic sensitivity of Lewis lung tumour. | Br J Cancer | 1977 | https://conductscience.org/library/papers/889677 | PubMed |
| 15 | 18418278 | Prognostic impact of primary tumor volume in patients with nasopharyngeal carcinoma treated by definitive radiation therapy. | Laryngoscope | 2008 | https://conductscience.org/library/papers/18418278 | PubMed |
| 16 | 18212229 | PET of hypoxia and perfusion with 62Cu-ATSM and 62Cu-PTSM using a 62Zn/62Cu generator. | AJR Am J Roentgenol | 2008 | https://conductscience.org/library/papers/18212229 | PubMed |
| 17 | 21609453 | Recurrence patterns of locally advanced head and neck squamous cell carcinoma after 3D conformal (chemo)-radiotherapy. | Radiat Oncol | 2011 | https://conductscience.org/library/papers/21609453 | PubMed |
| 18 | 22196796 | Adaptive radiotherapy using helical tomotherapy for head and neck cancer in definitive and postoperative settings: initial results. | Clin Oncol (R Coll Radiol) | 2012 | https://conductscience.org/library/papers/22196796 | PubMed |
| 19 | 12694833 | Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation. | Int J Radiat Oncol Biol Phys | 2003 | https://conductscience.org/library/papers/12694833 | PubMed |
| 20 | 17680220 | Locoregional failure analysis in head-and-neck cancer patients treated with IMRT. | Strahlenther Onkol | 2007 | https://conductscience.org/library/papers/17680220 | PubMed |
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42073589 | Multicenter Study of Multimodal MRI Radiomics and Deep Learning-Based Segmentation for Predicting Local Recurrence of Nasopharyngeal Carcinoma. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42073589 | PubMed |
| 41459851 | Dosimetric Determinants of Locoregional Failure in Nasopharyngeal Carcinoma Treated with Definitive Intensity-modulated Radiotherapy (IMRT) with or without Concomitant Chemotherapy. | Asian Pac J Cancer Prev | 2025 | https://conductscience.org/library/papers/41459851 | PubMed |
| 40197313 | Reirradiation based on diffusion-weighted magnetic resonance imaging-guided dose- painting for locally advanced recurrent nasopharyngeal carcinoma: a phase 2 randomized controlled trial. | BMC Cancer | 2025 | https://conductscience.org/library/papers/40197313 | PubMed |
| 39335592 | Recurrent Versus Metastatic Head and Neck Cancer: An Evolving Landscape and the Role of Immunotherapy. | Biomedicines | 2024 | https://conductscience.org/library/papers/39335592 | PubMed |
| 39308690 | PD-1 Inhibitors Combined with Chemotherapy versus Re-irradiation/chemoradiotherapy for Unresectable Locally Recurrent T3-4 Nasopharyngeal Carcinoma: A Retrospective Study. | J Cancer | 2024 | https://conductscience.org/library/papers/39308690 | PubMed |
| 38480535 | Salvage endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma in a non-endemic area. | Eur Arch Otorhinolaryngol | 2024 | https://conductscience.org/library/papers/38480535 | PubMed |
| 38169541 | Patterns and Prognosis of Local Recurrence of Nasopharyngeal Carcinoma after Intensity-modulated Radiotherapy. | J Cancer | 2024 | https://conductscience.org/library/papers/38169541 | PubMed |
| 38153435 | Is a total dose of 54 Gy with radiochemotherapy sufficient for treatment of intermediate-risk volumes in nasopharyngeal cancer? | Strahlenther Onkol | 2024 | https://conductscience.org/library/papers/38153435 | PubMed |
| 36944958 | Unraveling the patterns and pathways of local recurrence of nasopharyngeal carcinoma: evidence for individualized clinical target volume delineation. | Radiat Oncol | 2023 | https://conductscience.org/library/papers/36944958 | PubMed |
| 36386526 | Reconstruction of nasopharyngeal defect with submental flap during surgery for nasopharyngeal malignant tumors. | Front Surg | 2022 | https://conductscience.org/library/papers/36386526 | PubMed |
| 35954458 | Clinical Characteristics and Predictive Outcomes of Recurrent Nasopharyngeal Carcinoma-A Lingering Pitfall of the Long Latency. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35954458 | PubMed |
| 35223448 | Failure Patterns of Recurrence and Metastasis After Intensity-Modulated Radiotherapy in Patients With Nasopharyngeal Carcinoma: Results of a Multicentric Clinical Study. | Front Oncol | 2021 | https://conductscience.org/library/papers/35223448 | PubMed |
| 34699681 | The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma. | Cancer Commun (Lond) | 2021 | https://conductscience.org/library/papers/34699681 | PubMed |
| 34556123 | A novel dosimetric metrics-based risk model to predict local recurrence in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy. | Radiat Oncol | 2021 | https://conductscience.org/library/papers/34556123 | PubMed |
| 33955719 | Retreatment in locally recurrent nasopharyngeal carcinoma: Current status and perspectives. | Cancer Commun (Lond) | 2021 | https://conductscience.org/library/papers/33955719 | PubMed |
| 33544302 | Convolutional neural network in nasopharyngeal carcinoma: how good is automatic delineation for primary tumor on a non-contrast-enhanced fat-suppressed T2-weighted MRI? | Jpn J Radiol | 2021 | https://conductscience.org/library/papers/33544302 | PubMed |
| 33204320 | Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy. | Theranostics | 2020 | https://conductscience.org/library/papers/33204320 | PubMed |
| 33058559 | Clinical characteristics and survival outcomes of ascending, descending and mixed types of nasopharyngeal carcinoma in the non-endemic areas of china: A propensity score matching analysis. | Cancer Med | 2020 | https://conductscience.org/library/papers/33058559 | PubMed |
| 33017440 | Exploring MRI based radiomics analysis of intratumoral spatial heterogeneity in locally advanced nasopharyngeal carcinoma treated with intensity modulated radiotherapy. | PLoS One | 2020 | https://conductscience.org/library/papers/33017440 | PubMed |
| 32337354 | Effect of relevant factors on radiation-induced nasopharyngeal ulcer in patients with primary nasopharyngeal carcinoma treated with intensity-modulated radiation therapy. | Laryngoscope Investig Otolaryngol | 2020 | https://conductscience.org/library/papers/32337354 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24674015
GET https://conductscience.org/api/papers/v1/24674015/references?page=2